2025
SJR Q1
JCR Q1 · 4,3
49 eşleşen makale
SCIE
Dergi ayrıntısı
Regulatory Toxicology and Pharmacology
- Yayıncı
- Academic Press Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0273230010960295
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,12
- Quartile Q1
- H-Index 139
- Atıf/yayın 4,48
- Doküman (3y) 454
- Atıf (3y) 2.082
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,3
- 5Y JIF 4,5
- JCI 1,35
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Medicine (miscellaneous) Q1
- Toxicology Q1
Alanlar
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Medicine, Legal | Pharmacology & Pharmacy | Toxicology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,12 | 4,3 | 4,5 | 1,35 | Q1 | 139 |
| 2024 | Q1 | Q1 | 0,944 | 3,5 | 3,6 | 1,22 | Q1 | 131 |
| 2023 | Q2 | Q1 | 0,778 | 3 | 3,1 | 1,19 | Q1 | 131 |
| 2022 | Q2 | Q1 | 0,718 | 3,4 | 3,6 | 1,04 | Q1 | 131 |
| 2021 | Q2 | Q1 | 0,696 | 3,6 | 3,8 | 1,02 | Q1 | 131 |
| 2020 | Q2 | Q1 | 0,89 | 3,3 | 4,3 | 1,08 | Q1 | 131 |
| 2019 | Q2 | Q1 | 0,842 | 2,7 | 2,8 | 1,12 | Q1 | 131 |
| 2018 | — | Q1 | — | 3 | 2,8 | 1,15 | Q1 | — |
| 2017 | Q2 | Q1 | 0,812 | 2,8 | 2,5 | 1,18 | Q1 | 131 |
| 2016 | Q2 | Q1 | 0,724 | 2,2 | 2,1 | — | — | 131 |
| 2015 | Q2 | Q1 | 0,734 | 2,2 | 2,2 | — | — | 131 |
| 2014 | Q2 | Q2 | 0,75 | 2 | 2,3 | — | — | 131 |
| 2013 | Q2 | Q1 | 0,83 | 2,1 | 2,3 | — | — | 131 |
| 2012 | Q2 | Q2 | 0,81 | 2,1 | 2,4 | — | — | 131 |
| 2011 | Q1 | Q2 | 0,865 | 2,4 | 2,4 | — | — | 131 |
| 2010 | Q1 | Q2 | 0,926 | 2,2 | 2,4 | — | — | 131 |
| 2009 | — | Q2 | — | 1,8 | 2,1 | — | — | — |
| 2008 | — | Q1 | — | 2,4 | 2,6 | — | — | — |
| 2007 | — | Q2 | — | 2 | 2,2 | — | — | — |
| 2006 | — | Q1 | — | 1,8 | — | — | — | — |
| 2005 | — | Q2 | — | 1,6 | — | — | — | — |
| 2004 | — | Q1 | — | 1,6 | — | — | — | — |
| 2003 | — | Q2 | — | 1,4 | — | — | — | — |
| 2002 | — | Q1 | — | 1,5 | — | — | — | — |
| 2001 | — | Q1 | — | 1,5 | — | — | — | — |
| 2000 | — | Q2 | — | 1 | — | — | — | — |
| 1999 | — | Q2 | — | 1,5 | — | — | — | — |
| 1998 | — | Q2 | — | 1 | — | — | — | — |
| 1997 | — | Q3 | — | 0,9 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | MEDICINE, LEGAL | SCIE | Q1 | Q1 | 1/24 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 95/356 |
| 2025 | TOXICOLOGY | SCIE | Q2 | Q1 | 28/106 |
| 2024 | MEDICINE, LEGAL | SCIE | Q1 | Q1 | 1/22 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 107/352 |
| 2024 | TOXICOLOGY | SCIE | Q2 | Q1 | 32/106 |
| 2023 | MEDICINE, LEGAL | SCIE | Q1 | Q2 | 2/23 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 136/354 |
| 2023 | TOXICOLOGY | SCIE | Q2 | Q1 | 44/106 |
| 2022 | MEDICINE, LEGAL | SCIE | Q1 | Q2 | 1/17 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 125/278 |
| 2022 | TOXICOLOGY | SCIE | Q2 | Q1 | 34/94 |
| 2021 | MEDICINE, LEGAL | SCIE | Q1 | Q2 | 3/17 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 139/279 |
| 2021 | TOXICOLOGY | SCIE | Q2 | Q1 | 45/94 |
| 2020 | MEDICINE, LEGAL | SCIE | Q1 | Q2 | 3/17 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q1 | 148/276 |
| 2020 | TOXICOLOGY | SCIE | Q3 | Q1 | 49/93 |
| 2019 | MEDICINE, LEGAL | SCIE | Q1 | Q2 | 1/16 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q1 | 142/271 |
| 2019 | TOXICOLOGY | SCIE | Q3 | Q1 | 49/92 |
| 2018 | MEDICINE, LEGAL | SCIE | Q1 | Q1 | 2/17 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 104/267 |
| 2018 | TOXICOLOGY | SCIE | Q2 | Q1 | 40/93 |
| 2017 | MEDICINE, LEGAL | SCIE | Q1 | Q2 | 2/16 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 106/261 |
| 2017 | TOXICOLOGY | SCIE | Q2 | Q1 | 39/94 |
| 2016 | MEDICINE, LEGAL | SCIE | Q1 | — | 3/15 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 147/257 |
| 2016 | TOXICOLOGY | SCIE | Q3 | — | 51/92 |
| 2015 | MEDICINE, LEGAL | SCIE | Q1 | — | 3/15 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/255 |
| 2015 | TOXICOLOGY | SCIE | Q3 | — | 48/90 |
| 2014 | MEDICINE, LEGAL | SCIE | Q2 | — | 4/15 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 146/255 |
| 2014 | TOXICOLOGY | SCIE | Q3 | — | 56/88 |
| 2013 | MEDICINE, LEGAL | SCIE | Q1 | — | 4/16 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/256 |
| 2013 | TOXICOLOGY | SCIE | Q3 | — | 50/87 |
| 2012 | MEDICINE, LEGAL | SCIE | Q2 | — | 6/16 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/261 |
| 2012 | TOXICOLOGY | SCIE | Q3 | — | 49/85 |
| 2011 | MEDICINE, LEGAL | SCIE | Q2 | — | 4/15 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 115/261 |
| 2011 | TOXICOLOGY | SCIE | Q2 | — | 40/83 |
| 2010 | MEDICINE, LEGAL | SCIE | Q2 | — | 4/13 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/252 |
| 2010 | TOXICOLOGY | SCIE | Q3 | — | 47/83 |
| 2009 | MEDICINE, LEGAL | SCIE | Q2 | — | 4/11 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 149/237 |
| 2009 | TOXICOLOGY | SCIE | Q3 | — | 49/77 |
| 2008 | MEDICINE, LEGAL | SCIE | Q1 | — | 2/10 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 106/219 |
| 2008 | TOXICOLOGY | SCIE | Q2 | — | 34/75 |
| 2007 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/9 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 115/205 |
| 2007 | TOXICOLOGY | SCIE | Q2 | — | 36/73 |
| 2006 | MEDICINE, LEGAL | SCIE | Q1 | — | 2/9 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 105/199 |
| 2006 | TOXICOLOGY | SCIE | Q2 | — | 38/76 |
| 2005 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/9 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 115/193 |
| 2005 | TOXICOLOGY | SCIE | Q3 | — | 44/75 |
| 2004 | MEDICINE, LEGAL | SCIE | Q1 | — | 2/9 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 107/187 |
| 2004 | TOXICOLOGY | SCIE | Q3 | — | 40/75 |
| 2003 | MEDICINE, LEGAL | SCIE | Q2 | — | 4/9 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 105/185 |
| 2003 | TOXICOLOGY | SCIE | Q3 | — | 43/77 |
| 2002 | MEDICINE, LEGAL | SCIE | Q1 | — | 2/9 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 95/188 |
| 2002 | TOXICOLOGY | SCIE | Q2 | — | 34/76 |
| 2001 | MEDICINE, LEGAL | SCIE | Q1 | — | 1/8 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 84/186 |
| 2001 | TOXICOLOGY | SCIE | Q2 | — | 34/78 |
| 2000 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/9 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 113/181 |
| 2000 | TOXICOLOGY | SCIE | Q3 | — | 51/77 |
| 1999 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/10 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 65/175 |
| 1999 | TOXICOLOGY | SCIE | Q2 | — | 22/74 |
| 1998 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/9 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 98/178 |
| 1998 | TOXICOLOGY | SCIE | Q3 | — | 38/71 |
| 1997 | MEDICINE, LEGAL | SCIE | Q3 | — | 5/9 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 97/157 |
| 1997 | TOXICOLOGY | SCIE | Q3 | — | 38/63 |